Clinical Trial Update: A Study of the Recovery Benefits After Treatment With Parecoxib/Valdecoxib in Patients Undergoing Abdominal Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating parecoxib and valdecoxib for postoperative recovery after abdominal surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Bextra (valdecoxib)
• Dynastat

Snippet

Sponsor: Pfizer | Conditions: Pain | Phase 3 | Status: TERMINATED